European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors.
Ulrika JoneborgAlice BergaminiEmelie WallinGiorgia MangiliOlesya SolheimGloria MarquinaAntonio CasadoErik RokkonesJohn CoulterChristianne A R LokNienke van TrommelFrédéric AmantPierre-Adrien BolzeJalid SehouliSileny N HanFrédéric KridelkaFrederic GoffinPatricia PautierIsabelle Ray CoquardMichael J SecklPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Cross-border multidisciplinary tumor boards enable networking and clinical collaboration between healthcare professionals in different countries. Surveillance strategies, off-label drug use, and increased participation in clinical trials are possible benefits to patients with rare gynecological tumors.